Precision medicine for liver tumours with quantitative magnetic resonance imaging and whole genome sequencing (Precision1 trial): Study protocol for observational cohort study

Study protocol for Precision1 trial: an observational radiogenomics cohort in liver tumours. Primary endpoint: proportion of patients whose management would change based on whole-genome sequencing. Secondary aims assess decision impact of LiverMultiScan- and Hepatica, and correlate quantitative MRI with genomic and histologic features to guide precision care.